Literature DB >> 15986431

Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997.

Lars Klaeboe1, Stefan Lonn, David Scheie, Anssi Auvinen, Helle C Christensen, Maria Feychting, Christoffer Johansen, Tiina Salminen, Tore Tynes.   

Abstract

It has been reported that the incidence of meningioma increased in several industrialized countries in the late 1970s and early 1980s. The aim of this study was to evaluate the time trends in incidence of meningiomas in Denmark, Finland, Norway and Sweden, with emphasis on the age distribution and sex ratio. Information about cases of meningiomas in people aged 15-84 years was obtained from the cancer registries of these Nordic countries for the years 1968-1997, and estimates of person-years at risk were calculated from information provided by the national population registries. Age-specific incidence rates per 100,000 and incidence rate ratios were calculated for 3-year periods. The female:male ratios were also evaluated. The combined incidence among men increased from 1.4 to 1.9 per 100,000 during the follow-up period, the corresponding rates for women were 2.6 and 4.5. The female:male ratio increased over time for several age groups and was as high as 3.5:1 in the group aged 40-44 years in the latest follow-up period (1993-1997). In summary, our results provide some support for the idea that the introduction of computed tomography in the late 1970s has had an impact on the detection of cases in people aged 60 and over. The decrease in the rate or detection postmortem has affected the incidence time trend, but it also coincides with widespread use of new imaging technologies. The increasing trend shown for the female:male ratio in the group aged 35-59 years is consistent with the possibility that increasing use of hormones may affect the incidence of meningiomas in women. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 15986431     DOI: 10.1002/ijc.21255

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

Review 1.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

2.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

3.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

Review 4.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

5.  Epidemiology for primary brain tumors: a nationwide population-based study.

Authors:  Amélie Darlix; Sonia Zouaoui; Valérie Rigau; Faiza Bessaoud; Dominique Figarella-Branger; Hélène Mathieu-Daudé; Brigitte Trétarre; Fabienne Bauchet; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2016-11-16       Impact factor: 4.130

6.  A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas.

Authors:  Zhicen Li; Hao Li; Yuming Jiao; Ji Ma; Shuo Wang; Jizong Zhao; Yong Cao
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

7.  Double trouble: a tale of two radio-treatments.

Authors:  Ebere Sunny Ogbonnaya; Nikolay Peev; Sanjoy Nagaraja; Ronan Dardis
Journal:  BMJ Case Rep       Date:  2014-09-19

8.  Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study.

Authors:  Miguel Gil; Belén Oliva; Julia Timoner; Miguel A Maciá; Verónica Bryant; Francisco J de Abajo
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

9.  The potential involvement of E-cadherin and beta-catenins in meningioma.

Authors:  Keiyu Zhou; Guangtao Wang; Yirong Wang; Hanghuang Jin; Shuxu Yang; Chibo Liu
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

Review 10.  Advances in meningioma therapy.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.